Evidence map›Paper›PMID 28759485›Full record

ReviewAnesthesia and analgesia2018

Targeting Hypoxia Signaling for Perioperative Organ Injury.

Xiaoyi Yuan, Jae W Lee, Jessica L Bowser, Viola Neudecker, Srikanth Sridhar, Holger K Eltzschig

Abstract readReview
In one paragraph

Review in Anesthesia and analgesia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Article
  2. Article
  3. Effects and Mechanism of 2'-AMP on Renal Vascular Resistance: Role of P2X1 Receptors.Journal of the American Society of Nephrology : JASN · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Modulation of Neutrophil Recruitment and Inflammatory Signaling in Acute Respiratory Distress Syndrome by Leukotriene Inhibitors Montelukast and Zileuton.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. The effect of perioperative AKI on surgical outcomes.Anesthesiology and perioperative science · 2023
    Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaoyi YuanFrom the Department of Anesthesiology, the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas.
Jae W LeeFrom the Department of Anesthesiology, the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas.
Jessica L BowserFrom the Department of Anesthesiology, the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas.
Viola NeudeckerDepartment of Anesthesiology, Clinic of the University of Munich, Munich, Germany.
Srikanth SridharFrom the Department of Anesthesiology, the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas.
Holger K EltzschigFrom the Department of Anesthesiology, the University of Texas Health Science Center at Houston, McGovern Medical School, Houston, Texas.

Funding

Targeting the PI3K Signaling Pathway in Endometrial CarcinomaP50CA098258 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI YUAN, YING · 2003 to 2020
$32.0M
Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI James Versalovic · 2001 to 2026
$28.3M
Trangenic Mouse Breeding CoreP01HL114457 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ZHANG, YUJIN · 2013 to 2017
$10.0M
RESEARCH TRAINING IN LUNG DISEASET32HL007747 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI ROSAS, IVAN O. · 1993 to 2020
$5.1M
Novel Immunologic Effects of Semaphorin 7a in IPFR01HL109233 · NHLBI · YALE UNIVERSITY · PI HERZOG, ERICA L · 2011 to 2019
$3.7M
Hypoxia-Inducible Factors in Acetaminophen-Induced Liver Injury.R01DK109574 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K., JU, CYNTHIA · 2016 to 2019
$1.8M
Proton Pump Inhibitors for Perioperative Acute Kidney InjuryR01DK097075 · NIDDK · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2013 to 2017
$1.7M
Hypoxia Inducible Factor in Acute Lung InjuryR01HL098294 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI ELTZSCHIG, HOLGER K. · 2011 to 2014
$1.6M
Amphiregulin Signaling in Perioperative Cardio-ProtectionR01HL119837 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2014 to 2017
$1.5M
MicroRNA Shuttling during Acute Respiratory Distress SyndromeR01HL133900 · NHLBI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI ELTZSCHIG, HOLGER K. · 2017 to 2020
$1.5M
Reduction of kidney progressive fibrosis by A2A adenosine receptor activation: PR01DK082509 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI GARCIA, GABRIELA E · 2011 to 2015
$1.3M
NCI NIH HHS P50 CA098258NHLBI NIH HHS P01 HL114457NHLBI NIH HHS R01 HL098294NHLBI NIH HHS R01 HL109233NHLBI NIH HHS R01 HL119837NHLBI NIH HHS R01 HL133900NHLBI NIH HHS T32 HL007747NIDDK NIH HHS P30 DK056338NIDDK NIH HHS R01 DK082509NIDDK NIH HHS R01 DK097075NIDDK NIH HHS R01 DK109574
6 · The paper itself

Abstract

Perioperative organ injury has a significant impact on surgical outcomes and presents a leading cause of death in the United States. Recent research has pointed out an important role of hypoxia signaling in the protection from organ injury, including for example myocardial infarction, acute respiratory distress syndrome, acute kidney, or gut injury. Hypoxia induces the stabilization of hypoxia-inducible factors (HIFs), thereby leading to the induction of HIF target genes, which facilitates adaptive responses to low oxygen. In this review, we focus on current therapeutic strategies targeting hypoxia signaling in various organ injury models and emphasize potential clinical approaches to integrate these findings into the care of surgical patients. Conceptually, there are 2 options to target the HIF pathway for organ protection. First, drugs became recently available that promote the stabilization of HIFs, most prominently via inhibition of prolyl hydroxylase. These compounds are currently trialed in patients, for example, for anemia treatment or prevention of ischemia and reperfusion injury. Second, HIF target genes (such as adenosine receptors) could be activated directly. We hope that some of these approaches may lead to novel pharmacologic strategies to prevent or treat organ injury in surgical patients.

Indexed as

AnimalsGene TargetingHumansHypoxiaHypoxia-Inducible Factor 1Intraoperative ComplicationsMultiple Organ FailureSignal TransductionHypoxia-Inducible Factor 1

Identifiers

PMID28759485
PMCPMC5735013

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.